Sofosvel 400 Mg (Sofosbuvir & Velpatasvir)

Sofosvel 400 mg (Sofosbuvir & Velpatasvir)

Manufacturer: Beacon Pharmaceuticals Ltd.

Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for the treatment of patients with all genotypic Chronic Hepatitis C virus infections. Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).

Therapeutic indications:

Sofosvel is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
• With or without cirrhosis or with compensated cirrhosis
• With decompensated cirrhosis for use in combination with Ribavirin

Product Features:

Product Name : Sofosvel
Generic Name: Sofosbuvir 400mg Velpatasvir 100 mg
Formulation: Solid dosage form(Tablet)
Available Pack Size: 1×6’s
Available Strengths: 400mg 100mg
Categories: Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer: Beacon Pharmaceuticals Ltd.